Snow David P. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Sep 13, 2019
Insider Transaction Report
Form 4
Snow David P.
Chief Business Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-09-12+150,000→ 150,000 totalExercise: $6.47Exp: 2029-09-12→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on September 12, 2020, and the remainder vests in twelve equal quarterly installments thereafter.
- [F2]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.